IMPACT OF POPULATION PHARMACOKINETIC (PK) MODELING, LOGISTIC REGRESSION AND PK/PIIARMACODYNAMIC (PD) SIMULATION OF SOLABEGRON TO AID IN THE DOSE SELECTION OF A PHASE IIB STUDY IN PATIENTS WITH IRRITABLE BOWEL SYNDROME (IBS)

14

  • Cox, Donna S.
  • Eoyie, Duane A.
  • Fossler, Michael J.

  • Clinical Pharmacokinetics Modeling and Simulaliun, CPDM, GSK.

The Journal of Clinical Pharmacology 48(9):p 1101, September 2008.
Copyright © 2008 American College of Clinical Pharmacology